TABLE 8

Summary of plasma pharmacokinetics of PF-06282999 in healthy fasted male subjects after single p.o. doses administered as solution

Values are presented as follows: geometric means ± S.D. AUC, Cmax, CL/F, and Vz/F; medians (ranges) for Tmax; and arithmetic means ± S.D. for t1/2.

DoseAUC0–∞CmaxTmaxt1/2CL/FVz/F
mgng⋅h/mlng/mlhhml/minliters
201792 ± 363402 ± 1310.75 (0.5, 1.1)4.3 ± 0.7186 ± 4468.9 ± 10.8
504294 ± 664920 ± 2320.5 (0.5, 1.0)4.4 ± 0.6194 ± 3473.6 ± 11.5
12510,730 ± 19502659 ± 6310.5 (0.5, 1.0)4.4 ± 0.6194 ± 4073.7 ± 7.5
20016,950 ± 28803799 ± 11560.5 (0.5, 2.0)4.3 ± 0.4197 ± 3272.6 ± 7.2